NeuroSense Therapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for NRSN stock has a target of 7.50, which predicts an increase of 393.42% from the current stock price of 1.52.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$7.50	$7.50	$7.50	$7.50
Change	+393.42%	+393.42%	+393.42%	+393.42%

* Price targets were last updated on Jul 17, 2023.

Analyst Ratings

According to 1 stock analyst, the rating for NRSN is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Feb '24	Mar '24	Apr '24
Strong Buy	1	1	1
Buy	0	0	0
Hold	0	0	0
Sell	0	0	0
Strong Sell	0	0	0
Total	1	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
James Molloy Alliance Global Partners	Alliance Global Partners	Strong Buy Initiates $7.5	Strong Buy	Initiates	$7.5	+393.42%	Jul 17, 2023
Naz Rahman Maxim Group	Maxim Group	Strong Buy Initiates $7	Strong Buy	Initiates	$7	+360.53%	Jan 7, 2022

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-0.82

from -0.83

EPS Next Year

-0.82

from -0.82

Year	2019	2020	2021	2022	2023	2024	2025
Revenue	-	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-0.26	-0.51	-0.65	-1.07	-0.83	-0.82	-0.82
EPS Growth	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2024	2025
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2024	2025
High	-0.84	-0.84
Avg	-0.82	-0.82
Low	-0.78	-0.78

EPS Growth

EPS Growth	2024	2025
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.